ATE367799T1 - Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir - Google Patents

Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir

Info

Publication number
ATE367799T1
ATE367799T1 AT05713302T AT05713302T ATE367799T1 AT E367799 T1 ATE367799 T1 AT E367799T1 AT 05713302 T AT05713302 T AT 05713302T AT 05713302 T AT05713302 T AT 05713302T AT E367799 T1 ATE367799 T1 AT E367799T1
Authority
AT
Austria
Prior art keywords
delivery system
osmotic delivery
drug reservoir
prevent backflow
moderator
Prior art date
Application number
AT05713302T
Other languages
English (en)
Inventor
Li-Wei Pan
Rodney Panos
Eli Goldman
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE367799T1 publication Critical patent/ATE367799T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
    • A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons with secondary fluid driving or regulating the infusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
  • Catching Or Destruction (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT05713302T 2004-02-10 2005-02-09 Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir ATE367799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54342304P 2004-02-10 2004-02-10
US11/052,382 US20050175701A1 (en) 2004-02-10 2005-02-07 Capillary moderator for osmotic delivery system

Publications (1)

Publication Number Publication Date
ATE367799T1 true ATE367799T1 (de) 2007-08-15

Family

ID=34829897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05713302T ATE367799T1 (de) 2004-02-10 2005-02-09 Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir

Country Status (10)

Country Link
US (1) US20050175701A1 (de)
EP (1) EP1718275B1 (de)
JP (1) JP2007521887A (de)
AT (1) ATE367799T1 (de)
AU (1) AU2005212365A1 (de)
CA (1) CA2555887A1 (de)
DE (1) DE602005001765D1 (de)
NZ (1) NZ548716A (de)
TW (1) TW200539899A (de)
WO (1) WO2005077334A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
WO2003105803A1 (en) * 2002-06-17 2003-12-24 Alza Corporation Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2006521898A (ja) * 2003-03-31 2006-09-28 アルザ・コーポレーション 浸透送り出しシステム及び浸透送り出しシステムの始動時間を短縮する方法
US7207982B2 (en) * 2003-03-31 2007-04-24 Alza Corporation Osmotic pump with means for dissipating internal pressure
WO2005044239A2 (en) * 2003-10-31 2005-05-19 Alza Corporation Osmotic pump with self-retaining, fast-start membrane plug
KR20060121890A (ko) * 2003-11-06 2006-11-29 알자 코포레이션 이식형 삼투 펌프와 함께 사용하기 위한 모듈식 흡수율감소기
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP1877077A2 (de) * 2005-02-03 2008-01-16 Intarcia Therapeutics, Inc. Implantierbare interferonhaltige vorrichtung
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US7959938B2 (en) * 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
EP2020990B1 (de) 2006-05-30 2010-09-22 Intarcia Therapeutics, Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
PL2359808T3 (pl) * 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
CN104013569A (zh) * 2008-10-15 2014-09-03 精达制药公司 高浓缩药物颗粒、制剂、混悬剂及其应用
EP3323423B1 (de) * 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9956338B2 (en) 2012-07-06 2018-05-01 Sanofi-Aventis Deutschland Gmbh Drug delivery device
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
PL3370705T3 (pl) 2015-11-05 2022-08-01 The General Hospital Corporation Dooponowe dostarczanie sekwencji kwasów nukleinowych do kodowania abcd1 w leczeniu adrenomieloneuropatii
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
KR102687778B1 (ko) 2016-10-20 2024-07-23 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 신경 보호 폴리펩티드를 중추 신경계에 전달하는 방법
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
WO2018165462A1 (en) 2017-03-08 2018-09-13 Intarcia Therapeutics, Inc Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN110856987A (zh) * 2018-08-22 2020-03-03 东北林业大学 一种压力转换快速且便捷sls木塑复合材料后处理装置
AU2019357621B2 (en) 2018-10-11 2025-04-03 Intarcia Therapeutics, Inc. Human amylin analog polypeptides and methods of use
CN113548937B (zh) * 2020-04-26 2023-09-05 浙江蓝天环保高科技股份有限公司 一种高纯度全氟-2,4-二甲基-3-庚烯的连续制备方法
WO2025160155A1 (en) 2024-01-22 2025-07-31 The Broad Institute, Inc. Epigenetic targeting of prion diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760806A (en) * 1971-01-13 1973-09-25 Alza Corp Helical osmotic dispenser with non-planar membrane
US4455145A (en) * 1981-07-10 1984-06-19 Alza Corporation Dispensing device with internal drive
US4755180A (en) * 1986-06-16 1988-07-05 Alza Corporation Dosage form comprising solubility regulating member
DE69720190T2 (de) * 1996-02-02 2003-12-11 Alza Corp Implantierbares system mit verzögerter freisetzung von leuprolid
ZA981610B (en) * 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
ATE342051T1 (de) * 1997-12-30 2006-11-15 Alza Corp Verabreichungssystem für wirkstoffe mit einem membranstöpsel
AU773354B2 (en) * 1999-12-21 2004-05-20 Intarcia Therapeutics, Inc. Valve for osmotic devices
CA2460334A1 (en) * 2001-09-14 2003-03-27 Francis J. Martin Microfabricated nanopore device for sustained release of therapeutic agent
JP2007504920A (ja) * 2003-05-16 2007-03-08 ブルー メンブレーンス ゲーエムベーハー 生体適合性コーティングされた医療用インプラント

Also Published As

Publication number Publication date
TW200539899A (en) 2005-12-16
CA2555887A1 (en) 2005-08-25
JP2007521887A (ja) 2007-08-09
EP1718275A1 (de) 2006-11-08
DE602005001765D1 (de) 2007-09-06
WO2005077334A8 (en) 2006-07-06
US20050175701A1 (en) 2005-08-11
WO2005077334A1 (en) 2005-08-25
HK1097197A1 (en) 2007-06-22
AU2005212365A1 (en) 2005-08-25
NZ548716A (en) 2009-07-31
EP1718275B1 (de) 2007-07-25

Similar Documents

Publication Publication Date Title
DE602005001765D1 (de) Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir
WO2009086112A3 (en) Apparatus and methods for delivering therapeutic agents
EP1816995A4 (de) Kartusche, vorrichtung und verfahren zum aufbewahren, mischen und abgeben eines pharmazeutikums
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
GB2434548B (en) Devices, systems, and methods for medicament delivery
EA201000747A1 (ru) Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки
ATE498412T1 (de) System zur abgabe von flüchtigen stoffen
DK2902053T3 (da) Anordninger, systemer og fremgangsmåder til væskefremføring
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
ATE493161T1 (de) Medizinisches abgabesystem mit asymmetrischen kodiervorrichtungen
ATE485888T1 (de) Elektrobenetzende abgabevorrichtungen und dazugehörige verfahren
EP1910936A4 (de) System für anpassbare inhaltserzeugung,verwaltung und ablieferung
IL186458A0 (en) Skin enrichment using coq10 as the delivery system
GB0818178D0 (en) Devices, systems, and methods for medicament delivery
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
DE60216078D1 (de) Opioid enthaltende arzneiform gegen missbrauch
ATE521406T1 (de) Fluidadditivzufuhrsysteme
EP1784150A4 (de) Transdermales antiemese-abgabesystem, verfahren und zusammensetzung dafür
EP1795866A4 (de) Fussgänger-navigationssystem, informationsablieferungsserver und programm
CL2004000697A1 (es) Dispositivo de administracion osmotica que comprende: un reservorio, una composicion osmotica, la formulacion de la droga, y una membrana precargada que comprende un material semipermeable y un material liquido de relleno seleccionado de un polietile
ATE475484T1 (de) Dosiervorrichtung
EP1767783A4 (de) Druckerhöhungspumpe und diese umfassender speichertank für fluide auf niedrigen temperaturen
EP1867332A4 (de) Pharmazeutische zusammensetzung und verfahren unter verwendung eines antimykotischen mittels in kombination
DE602006019007D1 (de) Implantierbares arzneiabgabegerät
DE50010939D1 (de) Flüssigkeitsreservoir mit füllstandsmessung und dosiersystem, entnahmesystem sowie kombiniertes dosier/entnahmesystem

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties